Effect of Whole-Body Vibration During Chemotherapy in Improving Functional Outcomes of Patients with Malignancies
Author:
Shahid Wajiha,Jameel Waleed,Ahmad Irfan,Ali Aftab Asad,Ali Mehboob,Faiz Uzma,Ilyas Arooj,Attique Fatima
Abstract
The use of functional outcome scales to see the effect of whole-body vibration on the patients having malignancies and going through chemotherapy. Objective: To perform a systematic review to see the effects of whole-body vibration on patients having chemotherapy. Methods: Using the specified keywords, a search was conducted in the TRIP, PEDro and PubMed databases. The studies were picked based on their eligibility for evaluation. The articles having full length were included which specified the effect of whole-body vibration technique in the patients having malignancies and going through chemotherapy. Results: According to the exclusion criteria, three publications were included, all related to patients having chemotherapy. Reported were the effects of WBV both in sensory and motor symptoms. Conclusions: It was concluded that by using the whole-body vibrator the debilitating effects of the chemotherapy can be controlled or minimized such as fatigue, weakness and bone loss. It is comparative to high intensity exercises which account behavioral barriers and certain risks
Publisher
CrossLinks International Publishers
Reference22 articles.
1. 1. Cancer Index. Pakistan. 2019. [Last cited: 16th Mar 2023]. Available at: http://www.cancerindex.org/Pakistan.
2. 2. National Cancer Institute. Non-Hodgkin Lymphoma - Cancer Stat Facts. 2022. [Last cited: 16th Mar 2023]. Available at: https://seer.cancer.gov/statfacts/html/nhl.html.
3. 3. American Cancer Society. Survival Rates for Hodgkin Lymphoma. 2023. [Last cited: 16th Mar 2023]. Available at: https://www.cancer.org/cancer/hodgkin-lymphoma/detection-diagnosis-staging/survival-rates.html.
4. 4. American Cancer Society. Key Statistics for Hodgkin Lymphoma. 2023. [Last cited: 16th Mar 2023]. Available at: https://www.cancer.org/cancer/hodgkin-lymphoma/about/key-statistics.
5. 5. Mousa SA, Darwish N, Sudha T. Novel Thyrointegrin αvβ3 Antagonist for the Effective Management of Acute Myeloid Leukemia. Blood. 2020 Nov; 136: 5. doi: 10.1182/blood-2020-141628.